Answers are grounded in this paper and cite their sources.
development of drug resistance necessitates developing novel drugs or drug repurposing.Objective: This study aimed to investigate the efficacy of single doses of Ivermectin (IVM) versus ABZ inchildren infected with intestinal nematodes.Subjects and Methods: A total of 136 schoolchildren (6-15 years old) infected with T. trichiura, A.lumbricoides, and A. duodenale were enrolled in the study. They were divided into two treatment groups,68 in each, receiving either ABZ or IVM. At days 0 and 14 post-treatment, one stool Kato-Katz thick smearwas performed for cure assessment in ABZ and IVM treated groups. Blood samples were collected at thesame time points to determine absolute eosinophil count and IL-5 serum level as additional parametersto assess their prognostic role in drug efficacy.Results: Compared to the ABZ cure rate (CR), IVM showed equivalent efficacy in treating A. lumbricoides.However, it was unsuccessful in treating both T. trichiura and A. duodenale infections. High eosinophil countswere recorded in the infected rather than non-infected children and their levels dropped significantlyafter treatment with ABZ and IVM. High levels of IL-5 were observed in the infected children compared tonon-infected, with significant reduction after treatment with ABZ and IVM.Conclusion: A single dose of IVM is a promising therapy for A. lumbricoides but was inefficient for treatingT. trichiura and hookworm infections. Although eosinophil counts and serum interleukin-5 (IL5) levelsdecreased after treatment with ABZ and IVM, their function as effective prognostic parameters requiresmore research to establish their relevance.
No takes yet. Share an insight, caveat, or question.
Yahia et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: